Strategic Alliances: Synergistic Path to Value Creation Now Available at ReportsandReports

As the first decade of the 21st century comes to an end, the pharmaceutical industry is facing a major revenue downturn. The contributing factors are the expiration of patents on a number of blockbuster drugs and the stagnant productivity of R&D. As a consequence generics are expected to seriously erode revenues and the introduction of new proprietary drugs is not adequate.

Dallas, TX, May 06, 2010 --(PR.com)-- ReportsandReports Announce it Will Carry Strategic Alliances: Synergistic Path to Value Creation Market Research Report in its Store.

Browse the complete Report on: http://www.reportsandreports.com/market-reports/strategic-alliances-synergistic-path-to-value-creation/

As the first decade of the 21st century comes to an end, the pharmaceutical industry is facing a major revenue downturn. The contributing factors are the expiration of patents on a number of blockbuster drugs and the stagnant productivity of R&D. As a consequence generics are expected to seriously erode revenues and the introduction of new proprietary drugs is not adequate. The once insular pharmaceutical industry has been forced to look outside beyond its walls for drug pipeline candidates. The result has been an almost expediential growth of the past decade in the number and value of strategic alliances. This report analyses in detail the key driving forces behind the growth of strategies alliances and the changing characteristics of such deals to include:
- The pattern of escalating deal valuations
- Typical components of a strategic alliance
- Timely commentary for alliance executives
- Trends for future strategic alliance deals
- Recommendation for the future

Strategic Alliances: Synergistic Path to Value Creation reviews the structure of the past decade of strategic alliance deals in order to focus on the components, valuations and growth of such deals. Much of the growth in strategic alliances has been driven by the pharmaceutical industry’s need to add candidate products to its drug development pipelines. The industries internal R&D programs, despite escalating budget increases, have not been able to replace the blockbuster drugs coming off patent.

Table Of Contents
Chapter 1
Major Drivers Of Strategic Alliances
Chapter 2
The Productivity Gap
Chapter 3
Alliance Partnerships: A Historical Perspective
Chapter 4
Evaluation Of Selected Strategic Alliances During A Five
Uarter Period
Chapter 5
Big Ticket Strategic Alliances
Chapter 6
Financial Options Influencing The Formation Of Strategic
Alliances
Chapter 7
An Array Of Partnering Strategies And Options
References
Index
Tables, Boxes And Figures
Tables/Boxes
Figures

Related Reports:
Strategic Diagnostics Inc.-Deals & Alliances Report
http://www.reportsandreports.com/market-reports/strategic-diagnostics-inc-deals-alliances-report/

Alliance Pharmaceutical Corp.-Deals & Alliances Report
http://www.reportsandreports.com/market-reports/alliance-pharmaceutical-corp-deals-alliances-report/

The Future of Senior Nutrition: Key ingredients, strategic issues and targeted opportunities for older consumers
http://www.reportsandreports.com/market-reports/the-future-of-senior-nutrition-key-ingredients-strategic-issues/

About Us
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

###
Contact
ReportsandReports
Sunita Christ
+1-888-989-8004
http://www.reportsandreports.com
ContactContact
Categories